Prequalification Update - 24 February 2009
WHO Prequalification Programme adds the below 5 newly prequalified HIV/AIDS
product to its prequalified list
HA320: Lamivudine/Stavudine 150mg/30mg Tablets Aurobindo Pharma Ltd -
INDIA
HA321: Lamivudine/Stavudine 150mg/40mg Tablets Aurobindo Pharma Ltd -
INDIA
HA389: Efavirenz 200mg Tablets Strides Arcolab Limited - INDIA
HA390: Efavirenz 600mg Tablets Strides Arcolab Limited - INDIA
HA426: Lamivudine/Nevirapine/Zidovudine 150mg/200mg/300mg Tablets Matrix
Laboratories Ltd - INDIA
\\\\\\\\\\\
Prequalification Update - 19 February 2009
WHO Prequalification Programme adds the first generic lopinavir/ritonavir
product to its prequalified list
HA411: Lopinavir/Ritonavir 200mg/50mg Tablets Matrix Laboratories Ltd -
INDIA
\\\\\\\\\\\\
Prequalification Update - 18 February 2009
WHO Prequalification Programme publishes SPCs/WHO Public Assessment Reports
(WHOPARs)
The WHOPARs (marked in red in WHOPAR table) cover the following products:
HA330: Didanosine 250mg Capsules Bristol-Myers Squibb - France
HA331. Didanosine 400mg Capsules Bristol-Myers Squibb - France
HA332:Didanosine 2g Powder for oral solution Bristol-Myers Squibb - France
\\\\\\\\\\\\\\\\
Prequalification Update - 16 December 2008
WHO Prequalification Programme adds the first generic
artemether/lumefantrine product to its prequalified list
MA052: Artemether/Lumefantrine 20mg/120mg Tablets Ajanta Pharma
Ltd - INDIA
WHO Prequalification Programme adds the below new HIV/AIDS products to its
prequalified list
HA352: Efavirenz 600mg Tablets Cipla Ltd - INDIA
HA420: Lamivudine 300mg Tablets Matrix Laboratories
Limited - INDIA